Ghana Pharmaceuticals & Healthcare Q4 2019

Ghana Pharmaceuticals & Healthcare Q4 2019

Key View:

The actions of the National Medicine Price Committee will primarily benefit individual patients and institutional payers inGhana's pharmaceutical market. It will also provide some benefits to pharmaceutical companies operating in the country. A cap onpatented drug prices will, however, not be welcomed by foreign multinationals. Drugmakers should be aware that the Ghanaian cediwill see greater volatility in the short term.


Key View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Sub-Saharan Africa Innovative Pharmaceuticals Risk/Reward Index
Innovative Pharmaceuticals Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
Ayrton Drug Manufacturing Company (Adcock Ingram)
Danadams Pharmaceuticals Industry
Ghana Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook